LDX lumos diagnostics holdings limited

Another study by the same journal. This one was published...

  1. 1,845 Posts.
    lightbulb Created with Sketch. 174

    Another study by the same journal. This one was published yesterday and studies how to best integrate Point of Care Tests (POCT), like FebriDx into clinical practices.

    Seems like a lot of work is being done in this area, and LDX seem to have a prime product for centre stage in FebriDx.

    Link to study: https://bjgpopen.org/content/early/2024/11/11/BJGPO.2024.0112

    Aim:To explore factors that influence the adoption or non-adoption of POCT in English general practices and provide insights to enable its integration into routine practice workflows.

    Conclusion:General practices should demonstrate flexibility in the workflow and workforce they deploy to integrate POCT into routine clinical workflow.




    https://hotcopper.com.au/data/attachments/6606/6606642-94ae2f59c5525305c5d6ec78ced55a07.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.9¢
Change
0.000(0.00%)
Mkt cap ! $21.70M
Open High Low Value Volume
2.9¢ 2.9¢ 2.9¢ $1.912K 65.93K

Buyers (Bids)

No. Vol. Price($)
4 571666 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 150000 1
View Market Depth
Last trade - 10.42am 20/06/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.